Natco Pharma

quarterly
yearly
ParticularsDec '24Mar '25Jun '25Sep '25Dec '25
Revenue651.101,2871,3911,463705.40
Expenses487.40781.40818.70849.30544.30
EBITDA215.10614.40632.70679.20216.80
EBIT168.10516.10575.10626.80170.60
Profit Before Tax163.70505.90571.90613.70161.10
Net Profit132.40406.00480.30517.90140.40
Financial Ratios
Operating Profit Margin45.30%50.32%47.61%49.83%33.49%
Net Profit Margin28.01%33.30%36.17%38.03%23.40%
Earning Per Share (Diluted)7.4322.7026.8428.948.46
Dividends Per Share1.500.002.001.501.50